Intelligence Profile
Safety Profile
Exemestane Safety Profile
Known Side Effects:
Exemestane, an aromatase inhibitor, is generally used in the treatment of certain types of breast cancer. Common side effects associated with exemestane include hot flashes, fatigue, and joint pain. More serious side effects may include osteoporosis, cardiovascular issues, and liver dysfunction. A recent pharmacovigilance study (PMID: 42482750) highlighted the potential for tendon toxicity. Additionally, a study suggests exemestane may induce hepatotoxicity (PMID: 42541454).
Contraindications:
Evidence suggests that patients with known hypersensitivity to exemestane or any of its components should not use this medication. There is little direct evidence indicating additional specific contraindications, so clinical judgment is essential.
Drug Interactions:
Direct drug interaction data from the provided evidence is limited. Generally, caution should be used when prescribing exemestane with medications that affect liver enzyme activity, as exemestane is metabolized in the liver.
Populations to Avoid:
According to existing clinical guidelines, premenopausal women and pregnant women should avoid exemestane due to its mechanism of action and potential teratogenic effects. Additionally, the study on exemestane-induced cardiotoxicity (PMID: 42447938) suggests caution in patients with cardiovascular conditions.
Summary:
Exemestane is a critical therapy for hormone-sensitive breast cancer with a safety profile that includes common side effects like hot flashes and more severe risks like liver and cardiovascular complications. Individuals with certain pre-existing conditions, such as cardiovascular disease, may require careful monitoring or an alternative treatment approach.
Note:
This summary is based on available evidence and should not substitute personalized medical advice from a healthcare provider.